117 related articles for article (PubMed ID: 639004)
1. Serum selenium and reticuloendothelial tumors.
Broghamer WL; McConnell KP; Grimaldi M; Blotcky AJ
Cancer; 1978 Apr; 41(4):1462-6. PubMed ID: 639004
[TBL] [Abstract][Full Text] [Related]
2. The fibrinolytic enzyme system in haematological malignancy.
Dawson AA; Ogston D; Douglas AS
Bibl Anat; 1973; 12():272-8. PubMed ID: 4597632
[No Abstract] [Full Text] [Related]
3. [Changes in the activity of antihemophilic globulin (factor 8) after administration of adrenalin to patients with diseases of the reticuloendothelial system].
Pudlak P; Farska I; Horak J; Deimlova E
Nouv Rev Fr Hematol; 1968; 8(2):247-51. PubMed ID: 4232370
[No Abstract] [Full Text] [Related]
4. Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseases.
Child JA; Kushwaha MR
Hematol Oncol; 1984; 2(4):391-401. PubMed ID: 6396193
[TBL] [Abstract][Full Text] [Related]
5. [HL-A antigens and malignant hematological diseases].
Jeannet M; Alberto P; Wyss M
Schweiz Med Wochenschr; 1971 Dec; 101(49):1798-800. PubMed ID: 5291103
[No Abstract] [Full Text] [Related]
6. Serum selenium levels in malignant lymphoproliferative diseases.
Calautti P; Moschini G; Stievano BM; Tomio L; Calzavara F; Perona G
Scand J Haematol; 1980 Jan; 24(1):63-6. PubMed ID: 7367833
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell acetylcholinesterase activity and lysis in various dyshaemopoietic disorders.
Stathakis N; Papayannis AG; Scliros P; Gardikas C
Scand J Haematol; 1973; 11(3):210-6. PubMed ID: 4765536
[No Abstract] [Full Text] [Related]
8. [Quantitative measurement and clinical analysis of serum levels of immunosuppressive acidic protein (IAP) in hematopoietic malignancies].
Hamaguchi H; Karitani Y; Minami N; Tanaka I; Iwata Y; Shirakawa S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1231-6. PubMed ID: 6732251
[TBL] [Abstract][Full Text] [Related]
9. Treatment of malignancies of the reticuloendothelial system.
GHRIST TD
J Iowa State Med Soc; 1963 Feb; 53():72-82. PubMed ID: 13947558
[No Abstract] [Full Text] [Related]
10. Hormonal changes in patients with haematological malignancies.
Pavelic K; Pekic B; Gabrilovac J; Bratic-Mikes V; Boranic M
Biomedicine; 1981 Nov; 35(6):181-4. PubMed ID: 6279194
[TBL] [Abstract][Full Text] [Related]
11. [Determination of plasma fibronectin in myeloproliferative and lymphoproliferative diseases and other malignancies].
Kalabay L; Cseh K; Jakab L; Török J; Pozsonyi T; Marticsek J; Benedek S
Immun Infekt; 1986 Feb; 14(1):13-7. PubMed ID: 3082743
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies.
Takubo T; Kumura T; Nakao T; Nakamae H; Aoyama Y; Nishiki S; Kinoshita Y; Koh KR; Ohta K; Yamane T; Hino M; Kamitani T; Tatsumi N
Acta Haematol; 2000; 104(2-3):141-3. PubMed ID: 11154993
[No Abstract] [Full Text] [Related]
13. Evaluation of "virus-like" particles in the plasmas of 255 patients with leukemia and related diseases.
Newell GR; Harris WW; Bowman KO; Boone CW; Anderson NG
N Engl J Med; 1968 May; 278(22):1185-91. PubMed ID: 4172474
[No Abstract] [Full Text] [Related]
14. [Behavior of adenosine and adenosine triphosphatase phosphoric esters in systemic histiocytic sarcomatoses].
Mandelli F; Fontana L; Papa G; De Laurenzi A
Riv Emoter Immunoematol; 1967; 14(5):221-44. PubMed ID: 4244545
[No Abstract] [Full Text] [Related]
15. Reticuloendothelial malignancies; a pathologist's view.
Hameed K
Med Trial Tech Q; 1968 Mar; 14(3):29-38. PubMed ID: 5649316
[No Abstract] [Full Text] [Related]
16. [Diagnostic value of plasma fibronectin levels].
Cseh K; Kalabay L; Jakab L; Török J; Marticsek J; Benedek S; Pozsonyi T; Szklenárik G
Orv Hetil; 1986 Mar; 127(10):577-8, 581-2. PubMed ID: 3703538
[No Abstract] [Full Text] [Related]
17. [Total serum copper in histiocyte sarcomatosis with a systemic tendency].
Papa G; de Laurenzi A; Amadori S
Haematologica; 1972; 57(3):179-83. PubMed ID: 4625059
[No Abstract] [Full Text] [Related]
18. Vitamin E serum levels in patients with leukemia, lymphoma and myeloma.
Marco N; Gimferrer E; Mestres J; Ubeda J; Martino R; Altés A; Royo MT
Eur J Epidemiol; 1997 Oct; 13(7):853-4. PubMed ID: 9384278
[TBL] [Abstract][Full Text] [Related]
19. [Haptoglobin level in multiple myeloma, lymphatic leukemia and other proliferative disorders of the lymphoreticular system].
Cieśluk S; Snigurowicz J
Pol Tyg Lek; 1970 Jul; 25(28):1048-50. PubMed ID: 5468584
[No Abstract] [Full Text] [Related]
20. [Beta 2-microglobulin in lymphoproliferative disorders].
Leoni P; Sprovieri G; Recchioni A; Orrico C; Olivieri A
G Clin Med; 1983; 64(9-10):315-25. PubMed ID: 6363188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
